Prestige Consumer Healthcare Inc

Prestige Consumer Healthcare Inc

PBH - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.32B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Prestige Consumer Healthcare IncPrestige Consumer Healthcare Inc13.7-9%2.21.1

Earnings Call Q2 2023

November 6, 2022 - AI Summary

Q2 revenues of $289 million, up 5% organically compared to the prior year.
Strong sales performance driven by the International segment and the Hydralyte brand.
E-commerce business grew 15% in the first half of the year, outpacing other non-healthcare categories.

Exclusive for Stockcircle Pro members

Sign upSign Up
$122.32

Current Fair Value

145.8% upside

Undervalued by 145.8% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$2.32 Billion
Enterprise Value$4.30 Billion
Earnings per Share$3.93
Beta0.34
Outstanding Shares47,462,000

Return

Return on Equity8.97%ROE
Return on Assets3.77%
Return on Invested Capital6.33%

Valuation & Multiples

P/E Ratio13.67P/E Ratio
PEG-35.47PEG
Price to Sales2.16Price to Sales
Price to Book Ratio1.24Price to Book Ratio
Enterprise Value to Revenue3.89
Enterprise Value to EBIT15.37
Enterprise Value to Net Income24
Total Debt to Enterprise0.48
Debt to Equity1.08Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 6, 2026
EPS Estimate
$0.89
Consensus analyst estimate
Revenue Estimate
$253.02 M
Consensus analyst estimate

Next Earnings Call

Expected Date
November 5, 2026
EPS Estimate
$1.07
Consensus analyst estimate
Revenue Estimate
$329.14 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %3.74%▼ 110.92%
Total Invested$81.14M▼ 96.85%
Investors Holding79▼ 242.00%

About Prestige Consumer Healthcare Inc

Prestige Consumer Healthcare Insider Information FAQ

Stockcircle tracks 8 top investors with a current 13F position in Prestige Consumer Healthcare. Notable holders include Bridgewater Associates. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 5 top investors increased or opened positions and 3 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 4 open-market insider sales for Prestige Consumer Healthcare in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.